2 completed, 1 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Unknown 1 |
Follow Furunculosis: new trials by email Literature Review of Furunculosis trials Research Report on Furunculosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis Suppurativa adalimumab, placebo - Hidradenitis Suppurativa (HS) | Phase 3 | Completed | AbbVie (prior sponsor, Abbott) | 307 | 2011-11-01 | 2021-07-07 |
| Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa adalimumab, placebo - Hidradenitis Suppurativa (HS) | Phase 3 | Completed | AbbVie (prior sponsor, Abbott) | 326 | 2011-11-01 | 2021-07-12 |
| Open and Comparative Study to Measure Tolerability and Efficacy of Taro Elixir oxytetracycline, taro elixir, Taro Elixir - Acne Vulgaris II or III Degree, Boils | Phase 3 | Unknown | Laboratorios Goulart S.A. | 120 | 2010-05-01 | 2010-03-19 |
Acne Vulgaris (3) · Hidradenitis Suppurativa (2) · Psoriasis (2)
Acneiform Eruptions (3) · Animal Diseases (3) · Bacterial Infections (3) · Bacterial Infections and Mycoses (3) · Fish Diseases (3) · Gram-Positive Bacterial Infections (3) · Infections (3) · Sebaceous Gland Diseases (3) · Skin Diseases (3) · Skin Diseases, Bacterial (3) · Skin Diseases, Infectious (3) · Skin and Connective Tissue Diseases (3) · Staphylococcal Infections (3) · Staphylococcal Skin Infections (3) · Hidradenitis (2)
Adalimumab (2) · Oxytetracycline (1)
AbbVie (prior sponsor, Abbott) (2) · Laboratorios Goulart S.A. (1)
Brazil (1)
Andrea Gerbase (1) · Carlos Machado (1) · David Williams, MD (1) · Denise Steiner (1) · Jussara Marin (1) · Martin Okun, MD (1)